Telix Pharmaceuticals Limited
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $5.9M | $102.6M | $84.3M |
| FY2024 | $341.8M | $352.9M | $440.0M |
| FY2025 | $391.9M | $415.4M | $141.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $5.9M | $102.6M | $84.3M |
| FY2024 | $341.8M | $352.9M | $440.0M |
| FY2025 | $391.9M | $415.4M | $141.9M |